number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide iqvia Tirzepatide Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial Drugs like Ozempic now make

doi: 10.1111/j.1476-5381.2012.02068.x 60 DoveLSLemboARandallCWFogelRAndraeDDavenportJMet al

Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study

Irregular Heartbeat (Arrhythmia) Potassium is crucial for heart health

Clinical Scenarios: When to Use or DePrioritize Metformin Scenario 1: Newly Diagnosed, Low Cardiovascular Risk A 48-year-old patient with newly diagnosed type 2 diabetes, an A1C of 7.3%, and no cardiovascular risk factors may still benefit from starting metformin

A ratio of fluorescence intensities measured at 340 nm and 380 nm was calculated minus the background fluorescence

A global perspective on FOXO1 in lipid metabolism and lipid-related diseases